28.09.2017
- Drug development/manufacturing projects between pharma companies and CDMOs are based on mutual trust and a focus on success. How big of an issue is a merger or an acquisition for...
28.09.2017
- Will the consolidation in the pharmaceutical industry level off at any time soon or is it here to stay and will it even intensify? Denis Angioletti: Consolidation in the pharma...
28.09.2017
- Challenges caused by a merger or an acquisition can be manifold, no matter whether it is your own organization that is going through M&A and the integration phase or any of your...
27.09.2017
- The pharmaceutical industry is making a fundamental shift from a product- to a patient-outcome focused approach. Consequently, R&D organizations must also reflect this strategic...
27.09.2017
- Pharma Waldhof is active in the development and commercialization of active substances, key intermediates and reagents for multiple applications in the pharmaceutical, diagnostics...
27.09.2017
- 2017 marks the 200th anniversary of UK specialty chemical and technology group Johnson Matthey which – back in 1817 – began as assayers, testing the purity of precious metals. In...
27.09.2017
- Pharmaceutical companies have traditionally had complex operating models, but in recent years, complexity has reached a whole new level. Instead of continuously assessing their set...
27.09.2017
- In the shifting pharmaceutical landscape, contract manufacturing organizations (CMOs) and big pharma could see significant benefits. The findings of a new A.T. Kearney study can...
